Latest News about RMD

Recent news which mentions RMD

< Previous 1 2 3 4 5 6 7 8 Next >

Even the beleaguered tech sector has winners from rising inflation. Here are some of Credit Suisse’s favorites.

January 20, 2022

This Company Just Made a Possibly Lucrative Acquisition — What's Next?

January 14, 2022

What 4 Analyst Ratings Have To Say About ResMed

January 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2022

January 13, 2022

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021

December 06, 2021

3 Stocks to Add to Your Portfolio in the Event of a Market Downturn

November 17, 2021

Notable Resmed Insider Trades $2.9M In Company Stock

November 16, 2021

CNBC's Final Trades: Fiserv, ResMed, Monster Beverage And This Semiconductor Company

November 16, 2021

Required Minimum Distribution Changes for 2022

November 15, 2021

ResMed (RMD) Q1 2022 Earnings Call Transcript

October 29, 2021

The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs

October 29, 2021

The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug

October 28, 2021

Earnings Scheduled For October 28, 2021

October 28, 2021

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More

October 24, 2021

3 Leading Healthcare Stocks to Buy in 2021 and Beyond

October 19, 2021

3 Top Healthcare Stocks to Buy Right Now

October 13, 2021

3 Healthcare Stocks to Buy and Hold for the Next 10 Years

September 30, 2021

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test

September 10, 2021

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization

September 09, 2021

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod

September 08, 2021

Chief Administrative Officer Of Resmed Makes $434.44 Thousand Sell

September 07, 2021

President Of Resmed Makes $689.53 Thousand Sell

September 02, 2021

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

August 31, 2021

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal

August 24, 2021

Stocks That Hit 52-Week Highs On Monday

August 23, 2021

Stocks That Hit 52-Week Highs On Friday

August 20, 2021

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data

August 20, 2021

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck

August 19, 2021

Stocks That Hit 52-Week Highs On Wednesday

August 18, 2021

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline

August 18, 2021

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.